Executive Board
The Executive Board has been established to assist the Chief Executive in leading The Institute of Cancer Research to achieve its strategic aims and objectives within the approved strategies and budgets and is responsible for formulating strategies, plans and budgets for approval by the Board of Trustees.
Professor Kristian Helin
Chief Executive and President
Professor Kevin Harrington
Head of Division – Radiotherapy and Imaging
Professor Clare Isacke
Dean of Academic and Research Affairs
Paul Norris
Chief Financial Officer
Professor Jonathon Pines
Head of Division – Cell and Molecular Biology
Dr Barbara Pittam
Chief Research and Academic Officer
Dr Olivia Rossanese
Head of Division – Cancer Therapeutics
Latest ICR News
Subtle chemical tweak helps determine whether cells grow, potentially affecting cancer risk
Researchers have discovered a tiny chemical switch inside our cells that helps control whether they keep dividing or stop for good – a finding that could influence future cancer therapies and deepen our understanding of ageing.
Postdoc Maria Taskinen wins ICR Science and Medical Image Competition 2025
Seven images were shortlisted for this year’s annual Science and Medical Image competition, showcasing the eye-catching science being carried out at the ICR. Three winners were selected by a judging panel and the fourth was chosen by the public based on votes on social media.
New research reveals how combining viruses with targeted drugs can boost cancer-killing immune responses
Two studies have uncovered how combining a cancer-killing reovirus with targeted cancer drugs can dramatically boost immune responses and tumour destruction – offering a promising route to more effective, personalised cancer therapies.
How advances in microscopy are transforming structural biology at the ICR
At The Institute of Cancer Research, London, our ability to visualise the intricate inner workings of cancer is going from strength to strength. Robbie Lockyer spoke with scientists using cutting-edge imaging techniques to uncover how these tools are helping us understand cancer in unprecedented detail.